| Phenotype | Fish | Conditions | Figures | 
    
    
        
            | epidermal cell membrane ab1-llgl2 labeling spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell irregular spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell cdh1 expression increased amount, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell cdh1 expression spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | peridermal cell organelle membrane EGFP expression spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 1  , 
                    
                        Fig 4  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab2-cdh1 labeling spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | peridermal cell regulation of cell adhesion process quality, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 1  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab1-llgl2 labeling spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | peridermal cell delamination increased frequency, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 1  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab1-llgl2 labeling increased amount, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell delamination cellular spatiotemporal quality, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab2-cdh1 labeling increased amount, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | peridermal cell epithelial structure maintenance decreased process quality, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 1  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell increased thickness, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | peridermal cell plasma membrane EGFP expression spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b | standard conditions | Fig 1  , 
                    
                        Fig 4  from Phatak et al., 2021 
 | 
    
        
            | epidermis cdh1 expression increased amount, abnormal | TU + MO1-myo5b | standard conditions | Fig 3  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell delamination increased frequency, abnormal | TU + MO1-myo5b | standard conditions | Fig 4  , 
                    
                        Fig 5  from Phatak et al., 2021 
 | 
    
        
            | epidermis cldne expression increased amount, abnormal | TU + MO1-myo5b | standard conditions | Fig 3  from Phatak et al., 2021 
 | 
    
        
            | epidermis cldn7b expression increased amount, abnormal | TU + MO1-myo5b | standard conditions | Fig 3  from Phatak et al., 2021 
 | 
    
        
            | epidermis grhl3 expression increased amount, abnormal | TU + MO1-myo5b | standard conditions | Fig 3  from Phatak et al., 2021 
 | 
    
        
            | epidermis dsc2l expression increased amount, abnormal | TU + MO1-myo5b | standard conditions | Fig 3  from Phatak et al., 2021 
 | 
    
        
            | epidermis oclna expression increased amount, abnormal | TU + MO1-myo5b | standard conditions | Fig 3  from Phatak et al., 2021 
 | 
    
        
            | periderm cell population proliferation increased occurrence, abnormal | WT + MO1-myo5b | standard conditions | Fig. 5  from Sonal et al., 2014 
 | 
    
        
            | epidermal basal stratum cell population proliferation increased occurrence, abnormal | WT + MO1-myo5b | standard conditions | Fig. 5  from Sonal et al., 2014 
 | 
    
        
            | peridermal cell increased amount, abnormal | WT + MO1-myo5b | standard conditions | Fig. 5  from Sonal et al., 2014 
 | 
    
        
            | cell lysosome increased accumulation periderm, abnormal | zf106Tg + MO1-myo5b | standard conditions | Fig. 2  from Sonal et al., 2014 
 | 
    
        
            | peridermal cell apical plasma membrane decreased area, abnormal | zf106Tg + MO1-myo5b | standard conditions | Fig. 4  from Sonal et al., 2014 
 | 
    
        
            | peridermal cell decreased size, abnormal | zf106Tg + MO1-myo5b | standard conditions | Fig. 4  , 
                    
                        Fig. 5  from Sonal et al., 2014 
 | 
    
        
            | cell vesicle increased accumulation periderm, abnormal | zf106Tg + MO1-myo5b | standard conditions | Fig. 2  from Sonal et al., 2014 
 | 
    
        
            | peridermal cell cell projection membrane absent, abnormal | zf106Tg + MO1-myo5b | standard conditions | Fig. 4  from Sonal et al., 2014 
 | 
    
        
            | cell endosome increased accumulation periderm, abnormal | zf106Tg + MO1-myo5b | standard conditions | Fig. 2  from Sonal et al., 2014 
 | 
    
        
            | peridermal cell basolateral plasma membrane decreased area, abnormal | zf106Tg + MO1-myo5b | standard conditions | Fig. 4  from Sonal et al., 2014 
 | 
    
        
            | epidermal cell delamination normal frequency, ameliorated | grhl3zf3707/zf3707 + MO1-myo5b | standard conditions | Fig 4  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell delamination cellular spatiotemporal quality, abnormal | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | peridermal cell organelle membrane EGFP expression spatial pattern, ameliorated | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 4  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell membrane ab1-llgl2 labeling spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell decreased thickness, abnormal | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab1-llgl2 labeling spatial pattern, abnormal | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab2-cdh1 labeling spatial pattern, ameliorated | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab1-llgl2 labeling increased amount, abnormal | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell cell division increased frequency, abnormal | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | peridermal cell plasma membrane EGFP expression spatial pattern, ameliorated | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 4  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell irregular spatial pattern, exacerbated | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 6  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell ab2-cdh1 labeling amount, ameliorated | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell cdh1 expression amount, ameliorated | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell cdh1 expression spatial pattern, ameliorated | zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 7  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell delamination normal frequency, ameliorated | TU + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 4  from Phatak et al., 2021 
 | 
    
        
            | epidermal cell delamination increased frequency, exacerbated | TU + MO1-myo5b + MO4-grhl3 | standard conditions | Fig 5  from Phatak et al., 2021 
 | 
    
        
            | periderm cell decreased amount, abnormal | WT + MO1-myo5b + MO2-tp63 | standard conditions | Fig. 5  from Sonal et al., 2014 
 | 
    
        
            | peridermal cell apoptotic process increased occurrence, abnormal | WT + MO1-myo5b + MO2-tp63 | standard conditions | Fig. 5  from Sonal et al., 2014 
 |